allopurinol and Blood-Coagulation-Disorders

allopurinol has been researched along with Blood-Coagulation-Disorders* in 5 studies

Reviews

1 review(s) available for allopurinol and Blood-Coagulation-Disorders

ArticleYear
[Non-specific basic therapy of leukemias and their complications].
    Medizinische Klinik, 1974, Aug-23, Volume: 69, Issue:34

    Topics: Acute Disease; Adrenal Cortex Hormones; Allopurinol; Anemia; Autoimmune Diseases; Blood Coagulation Disorders; Blood Platelets; Blood Transfusion; Chronic Disease; Granulocytes; Humans; Infection Control; Leukemia; Uric Acid

1974

Other Studies

4 other study(ies) available for allopurinol and Blood-Coagulation-Disorders

ArticleYear
Coagulopathy mediated by hepatoenteric ischemia-reperfusion in rabbits: role of xanthine oxidase.
    Transplantation, 2002, Oct-27, Volume: 74, Issue:8

    Hepatic transplantation may result in coagulopathy caused by the release of mast-cell-derived heparin, and xanthine oxidase (XO) inhibition stabilizes mast cells. Thus, XO inactivation could decrease coagulopathy after hepatoenteric ischemia-reperfusion. Rabbits were fed a standard or XO-inactivating diet before hepatoenteric ischemia for 35 min and before 30 min of reperfusion. Hemostasis was assessed by thrombelastography. Heparin activity was quantified by anti-IIa. XO inactivation resulted in clot formation after reperfusion in all animals, whereas only 37.5% of animals with XO activity clotted (P<0.05). Anti-IIa activity was less in animals at baseline and after reperfusion with XO inactivation (45+/-5 and 65+/-5 mU/mL, respectively) compared to animals with XO activity (51+/-4 and 71+/-5 mU/mL, respectively) (P<0.05). Clot strength, which was mediated by coagulation proteins, was significantly greater at baseline and after reperfusion in animals with XO inactivation. XO inactivation enhances hemostasis by decreasing circulating heparin activity and increasing coagulation protein function before ischemia-reperfusion.

    Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Hemostasis; Heparin; Liver; Liver Transplantation; Male; Mast Cells; Rabbits; Reperfusion Injury; Xanthine Oxidase

2002
Thrombocytopenia and platelet dysfunction in orthotopic liver transplantation.
    Seminars in thrombosis and hemostasis, 1993, Volume: 19, Issue:3

    Topics: Adenosine; Allopurinol; Blood Coagulation Disorders; Blood Loss, Surgical; Blood Platelets; Glutathione; Humans; Insulin; Liver Transplantation; Organ Preservation; Organ Preservation Solutions; Platelet Aggregation; Raffinose; Reperfusion; Thrombocytopenia

1993
Treatment of adult leukemia with L-asparaginase (NSC-109229).
    Cancer chemotherapy reports, 1971, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Aged; Allopurinol; Anaphylaxis; Asparaginase; Blood Coagulation Disorders; Cytarabine; Daunorubicin; Drug Hypersensitivity; Female; Fever; Gastrointestinal Hemorrhage; Hallucinations; Humans; Hyperglycemia; Injections, Intravenous; Jaundice; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Liver; Male; Mercaptopurine; Methotrexate; Middle Aged; Oral Hemorrhage; Prednisone; Thioguanine; Uremia; Vincristine; Vomiting

1971
Adenosine metabolism in plasma and platelets. IV. Elevated plasmatic adenosine deaminase activity, impaired platelet 14C-adenosine incorporation and hemostatic dysfunction in chronic myeloid leukemia.
    Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research, 1970, Volume: 15, Issue:10

    Topics: Adenine Nucleotides; Allopurinol; Aminohydrolases; Blood Cell Count; Blood Coagulation Disorders; Blood Platelets; Carbon Isotopes; Chronic Disease; Hemoglobins; Humans; Leukemia, Myeloid; Nucleosides; Uric Acid

1970